Barrington Research Maintains Outperform on Stride, Maintains $125 Price Target
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and maintains $125 price target.
Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and maintains $125 price target.